Displaying 1 - 10 of 10
Viral Hepatitis

GSK: Time to rethink chronic hepatitis B: Quantitative hepatitis B surface antigen today and tomorrow (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

GSK: Unlocking the genetic architecture of Steatotic Liver Disease. A new paradigm in patient management (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

GSK: Meet the Experts - Genetic architecture of Steatotic Liver Disease (Complete Session)

Webcasts
View
Viral Hepatitis

GSK: Time to rethink chronic hepatitis B: A roadmap to functional cure (Complete Session)

Webcasts
View
Metabolism, Alcohol & Toxicity

The Growing Burden of MASLD/MASH: A Call to Action

Webcasts
View
Metabolism, Alcohol & Toxicity

AKH: Entering a New Era in Metabolic Dysfunction-Associated Steatohepatitis: Examining the Clinical Implications of Emerging D...

Webcasts
View
Metabolism, Alcohol & Toxicity

THR-β Agonists and Other Disease-specific Therapies Poised to Change the Paradigm

Webcasts
View
Metabolism, Alcohol & Toxicity

Rising to the Need to Improve Diagnosis in the Era of Disease-specific Therapy

Webcasts
View
Metabolism, Alcohol & Toxicity

Clinical Case Challenge: Integrating MASLD/MASH-Specific Therapy into Practice

Webcasts
View
Metabolism, Alcohol & Toxicity

Q&A

Webcasts
View
Displaying 1 - 10 of 10